Literature DB >> 6382018

Cancer: mutant ras proteins and cell transformation.

R Newbold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382018     DOI: 10.1038/310628a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  The H-ras oncogene product p21 and prognosis in human breast cancer.

Authors:  D M Watson; R A Elton; W J Jack; J M Dixon; U Chetty; W R Miller
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

Authors:  A K Ghosh; M Moore; M Harris
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  AMPKα2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis.

Authors:  Kathryn N Phoenix; Charan V Devarakonda; Melissa M Fox; Laura E Stevens; Kevin P Claffey
Journal:  Genes Cancer       Date:  2012-01

4.  Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.

Authors:  S C Tsai; R Adamik; J Moss; M Vaughan; V Manne; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 5.  Transforming ras oncogenes and multistage carcinogenesis.

Authors:  A Balmain
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

6.  Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.

Authors:  A Harlé; J Salleron; G Perkins; C Pilati; H Blons; P Laurent-Puig; J L Merlin
Journal:  Br J Cancer       Date:  2015-07-14       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.